Single and Multiple Ascending Dose Study With EP395

NCT04819854 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

78

Enrollment

INDUSTRY

Sponsor class

Conditions

Adult ALL

Interventions

DRUG: EP395
DRUG: Placebo

Sponsor

EpiEndo Pharmaceuticals